Boston Scientific to participate in Stifel's 2026 Healthcare Conference
Boston Scientific (NYSE: BSX) will participate in Stifel's 2026 Healthcare Conference on November 11, 2026, with a question-and-answer session.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Boston Scientific (NYSE: BSX) will participate in Stifel's 2026 Healthcare Conference on November 11, 2026, with a question-and-answer session.
Kenneth Stein, chief medical officer, and Lance Bates, president of Interventional Cardiology & Vascular Therapies, will join the 30-minute session at approximately 8:00 a.m. ET. A live webcast will be available on the investor website, with a replay approximately one hour after the event ends.
Details
Market Reaction – BSX
On Oct 26, the day this news came out, the latest delayed price for BSX is 0.74% below the previous close. The latest delayed price is $45.35. Relative volume is exceptionally heavy at 11.9x the average.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast and replay of the session will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-stifels-2026-healthcare-conference-302918819.html
SOURCE Boston Scientific Corporation